This form serves a dual purpose: as a prescription for Galafold and as a way for patients to register for AMICUS ASSIST.
DownloadThis form serves a dual purpose: as a prescription for Galafold and as a way for patients to register for AMICUS ASSIST.
DownloadDiscover more about the impact Fabry disease has on the kidneys and other organ systems, and how treatment with Galafold may help.
DownloadDiscover more about the impact Fabry disease has on the kidneys and other organ systems, and how treatment with Galafold may help.
DownloadHelp your patients establish a dosing regimen with Galafold by using the Galafold® MyDay app. Download this postcard to have on hand to give to your Galafold patients.
DownloadHelp your patients establish a dosing regimen with Galafold by using the Galafold® MyDay app. Download this postcard to have on hand to give to your Galafold patients.
DownloadAMICUS ASSIST is a program designed to provide assistance and support to help eligible patients with Fabry disease and an amenable GLA variant obtain access to Galafold.*
Understand more about the complexities of this disease, including signs, symptoms, how diagnosis can vary between genders, and much more.
Galafold® (migalastat) is indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene (GLA) variant based on in vitro assay data.
This indication is approved under accelerated approval based on reduction in kidney interstitial capillary cell globotriaosylceramide (KIC GL-3) substrate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.